Interestingly, a study by Mariathasan and colleagues showed that T cell exclusion in bladder cancer patients was attributed to stromal remodeling via TGFβ and revealed in a mammary mouse model that pharmacological blockade of TGFβ promotes T cell inflammation54. The gene discussed is TGFB1; the disease is urinary bladder cancer.